Ravandi, F., Yi, C. A., Cortes, J. E., Levis, M., Faderl, S., Garcia-Manero, G., . . . Kantarjian, H. (2014). Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients with Acute Myeloid Leukemia.
Dyfyniad Arddull ChicagoRavandi, Farhad, et al. Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients With Acute Myeloid Leukemia. 2014.
Dyfyniad MLARavandi, Farhad, et al. Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients With Acute Myeloid Leukemia. 2014.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.